Members |
targetComponentId |
Café-au-lait-pletter og ringkromosom 11 |
An autosomal anomaly with characteristics of variable clinical features, including early growth retardation and short stature, microcephaly, developmental delay, some degree of intellectual disability, facial dysmorphism and cafe-au-lait spots. In some cases, congenital heart disease and endocrine abnormalities have been reported. |
Calcaneum X-ray |
Plain X-ray of calcaneum |
Calcaneum X-ray |
Plain X-ray of calcaneum |
Calcipotriene 0.005%/betamethasone 0.064% topical suspension |
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) |
laksecalcitonin 100 enheder/ml injektionsvæske, opløsning, hætteglas a 1 ml |
Product containing precisely salmon calcitonin 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
laksecalcitonin 200 IE/ml spray |
Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug) |
Calcitonin, salmon 200unt/mL injection |
Salmon calcitonin 200 unit/mL solution for injection |
laksecalcitonin, 200 enheder/ml injektionsvæske, opløsning, hætteglas a 2 ml |
Salmon calcitonin 200 unit/mL solution for injection |
Calcium analyte |
Calcium |
calciumantacidum |
Calcium compound |
calciumcarbonat 1,25 g + cholecalciferol 11 µg brev granulat |
Calcium carbonate 6.25 mg/mL and colecalciferol 2.2 unit/mL oral solution |
calciumchlorid 10 %, injektionsvæske, opløsning i fyldt injektionssprøjte a 10 ml |
Product containing precisely calcium chloride 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
calciumhydroxylapatitmikrosfære, opløsning i vandbaseret bærer, i fyldt injektionssprøjte a 0,3 ml |
Hydroxyapatite only product in parenteral dose form |
calciumhydroxylapatitmikrosfære, opløsning i vandbaseret bærer, i fyldt injektionssprøjte a 1,3 ml |
Hydroxyapatite only product in parenteral dose form |
calciumphosphat 3100 mg + colecalciferol 20 µg pulver til oral suspension i brev |
Calcium phosphate and colecalciferol only product |
Calculus - composition |
Calculus chemical composition - finding |
Calculus analysis NOS |
Calculus analysis |
Calculus analysis NOS |
Calculus analysis |
Calculus chem. comp. NOS |
Determination of calculus chemical composition |
Calculus chemical composition NOS |
Determination of calculus chemical composition |
Calculus exam. general |
Calculus examination |
Calculus examination NOS |
Calculus examination |
Calculus examination NOS |
Calculus examination |
almindelig stenundersøgelse |
Calculus examination |
Calculus gen. exam. NOS |
Calculus examination |
Calculus general examination NOS |
Calculus examination |
Galdegangssten med akut kolecystit uden obstruktion |
Bile duct calculus with acute cholecystitis |
Galdegangssten med kronisk kolecystit uden obstruktion |
Calculus of bile duct with chronic cholecystitis |
Galdegangssten uden obstruktion |
Calculus of bile duct |
Sten i ductus choledochus med akut kolecystit uden obstruktion |
Calculus of common bile duct with acute cholecystitis |
Sten i ductus choledochus med kronisk kolecystit uden obstruktion |
Calculus of common bile duct with chronic cholecystitis |
Calculus of common bile duct without obstruction |
Common bile duct calculus |
Sten i ductus choledochus uden obstruktion |
Common bile duct calculus |
calfactant til intratrakeal anvendelse, suspension, hætteglas a 6 ml |
Product containing only calfactant (medicinal product) |
Calicivirus group |
Family Caliciviridae (organism) |
Calliphora erythrocephala |
Calliphora vicina |
Callitrogae |
Genus Cochliomyia (organism) |
Kalorieindtag |
Energy intake (observable entity) |
Caloscypha fulgens |
Caloscypha fulgens (organism) |
Calymmatobacterium granulomatis |
Klebsiella granulomatis (organism) |
bivirkning af camouflagepræparater |
Adverse reaction (disorder) |
Campylobacter cinaedi |
Helicobacter cinaedi |
Campylobacter fennelliae |
Helicobacter fennelliae |
Campylobacter laridis |
Campylobacter lari |
Campylobacter laridis rRNA |
Campylobacter lari rRNA |
Campylobacter laridis rRNA assay |
Campylobacter lari rRNA assay |
Campylobacter nitrofigilis |
Arcobacter nitrofigilis (organism) |
Canakinumab 150mg powder for injection solution |
Canakinumab only product |
Kanalpræparering og tilpasning af forformet dyvel eller søjle |
Preparation of root canal of tooth and insertion of preformed post |
Cancer care plan |
Cancer care plan |
cancerbehandlings- og plejeplan |
Cancer care plan |
Cancer care plan |
Cancer care plan |
gennemgang af cancerbehandling |
Cancer care review (procedure) |
screening for cancer i cervix gennemført |
Screening for malignant neoplasm of cervix done (situation) |
Candida famata |
Debaryomyces hansenii |
Candida famata |
Debaryomyces hansenii |
Candida guilliermondii var guilliermondii |
Meyerozyma guilliermondii (organism) |
Candida humicola |
Vanrija humicola (organism) |
Candida krusei var. vanlaeriana |
Pichia membranifaciens (organism) |
Candida lipolytica |
Yarrowia lipolytica |
Candida kefyr |
Kluyveromyces marxianus |
Candidiasis of other specified sites |
Candidiasis |
Candidiasis of other urogenital sites |
Candidiasis of urogenital site |
Canine cortical hyperostosis |
Disorder of bone (disorder) |
Canis familiaris |
Canis lupus subspecies familiaris (organism) |
Canis rufus |
Canis lupus subspecies rufus (organism) |
Cannabinoid |
Cannabis (substance) |
Cannabinoid - non-pharmaceutical |
Cannabis (substance) |
Cannabis dependence with current use |
Cannabis dependence |
ikke-farmaceutisk cannabisgræs |
Cannabis (substance) |
ikke-farmaceutiske cannabisblade |
Cannabis leaf (substance) |
ikke-farmaceutisk cannabisolie |
Cannabis oil (substance) |
ikke-farmaceutisk cannabisharpiks |
Cannabis resin (substance) |
Cannulation - action |
To put in between or into a part(s) of the body. |
Cannulation of vessel NOS |
Vascular cannula insertion |
Cannulation of vessel NOS |
Vascular cannula insertion |
kapillært hæmangiom iht. kategori |
Capillary hemangioma |
Capnocytophaga canimorsus |
Capnocytophaga canimorsus |
Caprine adenovirus |
Goat adenovirus (organism) |
Capsaicin 179mg/hour transdermal patch |
Product containing precisely capsaicin 179 milligram/1 each conventional release cutaneous patch (clinical drug) |
kapsel i distalt interfalangealled i storetå |
Structure of capsule of interphalangeal joint of great toe |
allergi over for captopril |
Non-allergic hypersensitivity to captopril (finding) |
carbachol 1 % øjendråber |
Product containing precisely carbachol 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
carbachol 1,5 % øjendråber |
Carbachol 15 mg/mL eye solution |
Carbachol 1.5% solution |
Carbachol 15 mg/mL eye solution |
carbachol 250 µg/ml injektionsvæske, opløsning, ampul a 1 ml |
Product containing precisely carbachol 250 microgram/1 milliliter conventional release solution for injection (clinical drug) |
carbamazepin kapsel med modificeret udløsning a 100 mg |
Carbamazepine only product in oral dose form |
carbamazepin 100 mg tablet med modificeret udløsning |
Carbamazepine only product in oral dose form |
Carbamazepine 100mg prolonged-release oral capsule |
Carbamazepine only product in oral dose form |
Carbamazepine 100mg prolonged-release oral tablet |
Carbamazepine only product in oral dose form |
carbamazepin kapsel med modificeret udløsning a 200 mg |
Carbamazepine only product in oral dose form |
Carbamazepine 200mg prolonged-release oral capsule |
Carbamazepine only product in oral dose form |
carbamazepin kapsel med modificeret udløsning a 300 mg |
Carbamazepine only product in oral dose form |
Carbamazepine 300mg prolonged-release oral capsule |
Carbamazepine only product in oral dose form |
carbenoxolonnatrium 1 % granulat til mundskyllevæske |
Carbenoxolone only product |
carbenoxolonnatrium 2 % oral gel |
Carbenoxolone 20 mg/g oromucosal gel |
carbidopa 25 mg + levodopa 100 mg tablet med modificeret udløsning |
Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet |
carbidopa 50 mg + levodopa 200 mg tablet med modificeret udløsning |
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) |
carbidopa 10 mg + levodopa 100 mg oralt opløselig tablet |
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Carbidopa 18.75mg + levodopa 75mg + entacapone 200mg tablet |
Carbidopa anhydrous (as carbidopa) 18.75 mg and entacapone 200 mg and levodopa 75 mg oral tablet |
Carbidopa 25mg |
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram/1 each conventional release oral tablet (clinical drug) |